CEPI – a new global R&D organisation for epidemic preparedness and response

by Børge Brende, Jeremy Farrar, Diane Gashumba et al.
The Lancet – Published: 18 January 2017

3 pp. 66 kB
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(17)30131-9.pdf

During the World Economic Forum 2016 meeting a consensus emerged on the need for a new approach to public–private collaboration to address epidemics and for exploring the establishment of a new financing mechanism. Now, CEPI – the Coalition for Epidemic Preparedness Innovations, a partnership between public, private, philanthropic, non-governmental, intergovernmental, and civil organisations, is launched on January 19 at the World Economic Forum’s 2017 meeting. CEPI will be based in Oslo, Norway, with offices in the UK, India, and the USA, but will be a global organisation with partners on all continents. CEPI provides a new funding model for the development of vaccines against epidemic infectious diseases through pooling resources from several investors. This coalition will build a new system to advance the development of safe, effective, and affordable vaccines, ensuring that price is not a barrier to access for populations most at need.

(Visited 26 times, 1 visits today)
This entry was posted in Essential Medicines, General, Other Infectious Diseases. Bookmark the permalink.